Sun Pharma Advanced Research Company Limited reported earnings results for the third quarter and nine months ended December 31, 2023. For the third quarter, the company reported sales was INR 138.6 million. Revenue was INR 202.5 million. Net loss was INR 996.5 million. Basic loss per share from continuing operations was INR 3.07. Diluted loss per share from continuing operations was INR 3.07.
For the nine months, sales was INR 589.9 million. Revenue was INR 840.6 million. Net loss was INR 2,814.2 million. Basic loss per share from continuing operations was INR 8.67. Diluted loss per share from continuing operations was INR 8.67.